Document:

Exhibit 10.5

 

Olema
Pharmaceuticals, Inc.

RSU Award Grant Notice

(2020
Equity Incentive Plan)

 

Olema Pharmaceuticals, Inc. (the “Company”)
has awarded to you (the “Participant”) the number of restricted stock units specified and on the terms
set forth below in consideration of your services (the “RSU Award”). Your RSU Award is subject to all
of the terms and conditions as set forth herein and in the Company’s 2020 Equity Incentive Plan (the “Plan”)
and the Award Agreement (the “Agreement”), which are incorporated herein in their entirety. Capitalized
terms not explicitly defined herein but defined in the Plan or the Agreement shall have the meanings set forth in the Plan or the
Agreement.

 

	Participant:	 	 
	Date
    of Grant:	 	 
	Vesting
    Commencement Date:	 	 
	Number
    of Restricted Stock Units:	 	 

 

Vesting
Schedule: [__________________________________________________________________].

Notwithstanding the foregoing, vesting
shall terminate upon the Participant’s termination of Continuous Service.

 

Issuance
Schedule:One share of Common Stock will be issued for each restricted stock unit which vests at the time set forth in Section
5 of the Agreement.

 

Participant Acknowledgements: By
your signature below or by electronic acceptance or authentication in a form authorized by the Company, you understand and agree
that:

 

	·	The RSU Award is governed by this RSU Award Grant Notice (the “Grant Notice”),
and the provisions of the Plan and the Agreement, all of which are made a part of this document. Unless otherwise provided in the
Plan, this Grant Notice and the Agreement (together, the “RSU Award Agreement”) may not be modified,
amended or revised except in a writing signed by you and a duly authorized officer of the Company.
	 	 
	·	You have read and are familiar with the provisions of the Plan, the RSU Award Agreement
and the Prospectus. In the event of any conflict between the provisions in the RSU Award Agreement, or the Prospectus and the terms
of the Plan, the terms of the Plan shall control.
	 	 
	·	The RSU Award Agreement sets forth the entire understanding between you and the Company
regarding the acquisition of Common Stock and supersedes all prior oral and written agreements, promises and/or representations
on that subject with the exception of: (i) other equity awards previously granted to you, and (ii) any written employment agreement,
offer letter, severance agreement, written severance plan or policy, or other written agreement between the Company and you in
each case that specifies the terms that should govern this RSU Award.

 

	Olema
    Pharmaceuticals, Inc.	 	Participant:
	 	 	 
	By:	 	 	 
	 	Signature	 	Signature
	 	 	 
	Title:	                        	 	Date:	             
	 	 	 
	Date:	 	 	 

 

     

     

    

 

Olema
Pharmaceuticals, Inc.

2020
Equity Incentive Plan

 

Award
Agreement (RSU Award)

 

As reflected by your
Restricted Stock Unit Grant Notice (“Grant Notice”), Olema Pharmaceuticals, Inc. (the “Company”)
has granted you a RSU Award under its 2020 Equity Incentive Plan (the “Plan”) for the number of restricted
stock units as indicated in your Grant Notice (the “RSU Award”). The terms of your RSU Award as specified
in this Award Agreement for your RSU Award (the “Agreement”) and the Grant Notice constitute your “RSU
Award Agreement”. Defined terms not explicitly defined in this Agreement but defined in the Grant Notice or the Plan
shall have the same definitions as in the Grant Notice or Plan, as applicable.

 

The general terms applicable
to your RSU Award are as follows:

 

1.                 
Governing Plan Document. Your RSU Award is subject to all the provisions
of the Plan. Your RSU Award is further subject to all interpretations, amendments, rules and regulations, which may from time to
time be promulgated and adopted pursuant to the Plan. In the event of any conflict between the RSU Award Agreement and the provisions
of the Plan, the provisions of the Plan shall control.

 

2.                 
Grant of the RSU Award. This RSU Award represents your right to be issued
on a future date the number of shares of the Company’s Common Stock that is equal to the number of restricted stock units
indicated in the Grant Notice subject to your satisfaction of the vesting conditions set forth therein (the “Restricted
Stock Units”). Any additional Restricted Stock Units that become subject to the RSU Award pursuant to Capitalization
Adjustments as set forth in the Plan and the provisions of Section 3 below, if any, shall be subject, in a manner determined by
the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of delivery as applicable
to the other Restricted Stock Units covered by your RSU Award.

 

3.                 
Dividends. You shall receive no benefit or adjustment to your RSU Award
with respect to any cash dividend, stock dividend or other distribution that does not result from a Capitalization Adjustment as
provided in the Plan; provided, however, that this sentence shall not apply with respect to any shares of Common Stock that are
delivered to you in connection with your RSU Award after such shares have been delivered to you.

 

4.                 
Withholding Obligations.

 

(a)               Regardless
of any action taken by the Company or, if different, the Affiliate to which you provide Continuous Service (the
 “Service Recipient”) with respect to any income tax, social insurance, payroll tax, fringe benefits
tax, payment on account or other tax-related items associated with the grant or vesting of the RSU Award or sale of the
underlying Common Stock or other tax-related items related to your participation in the Plan and legally applicable to you
(the “Tax Liability”), you hereby acknowledge and agree that the Tax Liability is your ultimate
responsibility and may exceed the amount, if any, actually withheld by the Company or the Service Recipient. You further
acknowledge that the Company and the Service Recipient (i) make no representations or undertakings regarding any Tax
Liability in connection with any aspect of this RSU Award, including, but not limited to, the grant or vesting of the RSU
Award, the issuance of Common Stock pursuant to such vesting, the subsequent sale of shares of Common Stock, and the payment
of any dividends on the Common Stock; and (ii) do not commit to and are under no obligation to structure the terms of the
grant or any aspect of the RSU Award to reduce or eliminate your Tax Liability or achieve a particular tax result. Further,
if you are subject to Tax Liability in more than one jurisdiction, you acknowledge that the Company and/or the Service
Recipient (or former service recipient, as applicable) may be required to withhold or account for Tax Liability in more than
one jurisdiction.

 

    1.

     

    

 

(b)             
Prior to any relevant taxable or tax withholding event, as applicable, you agree to make adequate arrangements satisfactory
to the Company and/or the Service Recipient to satisfy all Tax Liability. As further provided in Section 8 of the Plan, you hereby
authorize the Company and any applicable Service Recipient to satisfy any applicable withholding obligations with regard to the
Tax Liability by any of the following means or by a combination of such means: (i) causing you to pay any portion of the Tax Liability
in cash or cash equivalent in a form acceptable to the Company; (ii) withholding from any compensation otherwise payable to you
by the Company or the Service Recipient; (iii) withholding shares of Common Stock from the shares of Common Stock issued or otherwise
issuable to you in connection with the Award; provided, however, that to the extent necessary to qualify for an exemption
from application of Section 16(b) of the Exchange Act, if applicable, such share withholding procedure will be subject to the express
prior approval of the Board or the Company’s Compensation Committee; (iv) permitting or requiring you to enter into a “same
day sale” commitment, if applicable, with a broker-dealer that is a member of the Financial Industry Regulatory Authority
(a “FINRA Dealer”), pursuant to this authorization and without further consent, whereby you irrevocably
elect to sell a portion of the shares of Common Stock to be delivered in connection with your Restricted Stock Units to satisfy
the Tax Liability and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the Tax Liability
directly to the Company or the Service Recipient; and/or (v) any other method determined by the Company to be in compliance with
Applicable Law. Furthermore, you agree to pay the Company or the Service Recipient any amount the Company or the Service Recipient
may be required to withhold, collect, or pay as a result of your participation in the Plan or that cannot be satisfied by the means
previously described. In the event it is determined that the amount of the Tax Liability was greater than the amount withheld by
the Company and/or the Service Recipient (as applicable), you agree to indemnify and hold the Company and/or the Service Recipient
(as applicable) harmless from any failure by the Company or the applicable Service Recipient to withhold the proper amount.

 

(c)               The
Company may withhold or account for your Tax Liability by considering statutory withholding amounts or other withholding
rates applicable in your jurisdiction(s), including (i) maximum applicable rates in your jurisdiction(s), in which case you
may receive a refund of any over-withheld amount in cash (whether from applicable tax authorities or the Company) and you
will have no entitlement to the equivalent amount in Common Stock or (ii) minimum or such other applicable rates in your
jurisdiction(s), in which case you may be solely responsible for paying any additional Tax Liability to the applicable tax
authorities or to the Company and/or the Service Recipient. If the Tax Liability withholding obligation is satisfied by
withholding shares of Common Stock, for tax purposes, you are deemed to have been issued the full number of shares of Common
Stock subject to the vested portion of the RSU Award, notwithstanding that a number of the shares of Common Stock is held
back solely for the purpose of paying such Tax Liability.

 

    2.

     

    

 

(d)             
You acknowledge that you may not participate in the Plan and the Company shall have no obligation to deliver shares
of Common Stock until you have fully satisfied the Tax Liability, as determined by the Company. Unless any withholding obligation
for the Tax Liability is satisfied, the Company shall have no obligation to deliver to you any Common Stock in respect of the RSU
Award.

 

5.                 
Date of Issuance. 

 

(a)              
The issuance of shares in respect of the Restricted Stock Units is intended to comply with U.S. Treasury Regulations
Section 1.409A-3(a) and will be construed and administered in such a manner. Subject to the satisfaction of the Tax Liability withholding
obligation, if any, in the event one or more Restricted Stock Units vests, the Company shall issue to you one (1) share of Common
Stock for each vested Restricted Stock Unit. Each issuance date determined by this paragraph is referred to as an “Original
Issuance Date.”

 

(b)             
If the Original Issuance Date falls on a date that is not a business day, delivery shall instead occur on the next following
business day. In addition, if:

 

(i)                
the Original Issuance Date does not occur (1) during an “open window period” applicable to you, as determined
by the Company in accordance with the Company’s then-effective policy on trading in Company securities, or (2) on a date
when you are otherwise permitted to sell shares of Common Stock on an established stock exchange or stock market (including but
not limited to under a previously established written trading plan that meets the requirements of Rule 10b5-1 under the Exchange
Act and was entered into in compliance with the Company’s policies (a “10b5-1 Arrangement)), and

 

(ii)              either
(1) a Tax Liability withholding obligation does not apply, or (2) the Company decides, prior to the Original Issuance Date,
(A) not to satisfy the Tax Liability withholding obligation by withholding shares of Common Stock from the shares otherwise
due, on the Original Issuance Date, to you under this Award, and (B) not to permit you to enter into a “same day
sale” commitment with a broker-dealer (including but not limited to a commitment under a 10b5-1 Arrangement) and (C)
not to permit you to pay your Tax Liability in cash, then the shares that would otherwise be issued to you on the
Original Issuance Date will not be delivered on such Original Issuance Date and will instead be delivered on the first
business day when you are not prohibited from selling shares of the Common Stock in the open public market, but in no event
later than December 31 of the calendar year in which the Original Issuance Date occurs (that is, the last day of your taxable
year in which the Original Issuance Date occurs), or, if and only if permitted in a manner that complies with U.S.
Treasury Regulations Section 1.409A-1(b)(4), no later than the date that is the 15th day of the third calendar month of the
applicable year following the year in which the shares of Common Stock under this Award are no longer subject to a
 “substantial risk of forfeiture” within the meaning of U.S. Treasury Regulations Section 1.409A-1(d).

 

    3.

     

    

 

6.                 
Transferability. Except as otherwise provided in the Plan, your RSU Award
is not transferable, except by will or by the applicable laws of descent and distribution

 

7.                 
Corporate Transaction. Your RSU Award is subject to the terms of any agreement
governing a Corporate Transaction involving the Company, including, without limitation, a provision for the appointment of a stockholder
representative that is authorized to act on your behalf with respect to any escrow, indemnities and any contingent consideration.

 

8.                 
No Liability for Taxes. As a condition to accepting the RSU Award, you
hereby (a) agree to not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related
to tax liabilities arising from the RSU Award or other Company compensation and (b) acknowledge that you were advised to consult
with your own personal tax, financial and other legal advisors regarding the tax consequences of the RSU Award and have either
done so or knowingly and voluntarily declined to do so.

 

9.                 
Severability. If any part of this Agreement or the Plan is declared by
any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion
of this Agreement or the Plan not declared to be unlawful or invalid.  Any Section of this Agreement (or part of such
a Section) so declared to be unlawful or invalid will, if possible, be construed in a manner which will give effect to the terms
of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.

 

10.             
Other Documents.  You hereby acknowledge receipt of or the right
to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes
the Prospectus.  In addition, you acknowledge receipt of the Company’s Trading Policy.

 

11.             
Questions.  If you have questions regarding these or any other terms and
conditions applicable to your RSU Award, including a summary of the applicable federal income tax consequences please see the Prospectus.

 

    4.Exhibit 10.6

 

Olema
Pharmaceuticals, Inc.

2020 Employee Stock Purchase Plan

 

Adopted
by the Board of Directors: _____________, 2020

Approved
by the Stockholders: ______________, 2020

IPO
Date: ______________, 2020

 

1.            
General; Purpose.

 

(a)          
The Plan provides a means by which Eligible Employees of the Company and certain Designated Companies may be given an
opportunity to purchase shares of Common Stock. The Plan permits the Company to grant a series of Purchase Rights to Eligible Employees
under an Employee Stock Purchase Plan. In addition, the Plan permits the Company to grant a series of Purchase Rights to Eligible
Employees that do not meet the requirements of an Employee Stock Purchase Plan.

 

(b)          
The Plan includes two components: a 423 Component and a Non-423 Component. The Company intends (but makes no undertaking
or representation to maintain) the 423 Component to qualify as an Employee Stock Purchase Plan. The provisions of the 423 Component,
accordingly, will be construed in a manner that is consistent with the requirements of Section 423 of the Code. Except as otherwise
provided in the Plan or determined by the Board, the Non-423 Component will operate and be administered in the same manner as the
423 Component.

 

(c)           
The Company, by means of the Plan, seeks to retain the services of such Employees, to secure and retain the services
of new Employees and to provide incentives for such persons to exert maximum efforts for the success of the Company and its Related
Corporations.

 

2.            
Administration.

 

(a)          
The Board or the Committee will administer the Plan. References herein to the Board shall be deemed to refer to the
Committee except where context dictates otherwise.

 

(b)          
The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:

 

(i)                
To determine how and when Purchase Rights will be granted and the provisions of each Offering (which need not be identical).

 

(ii)              
To designate from time to time (A) which Related Corporations will be eligible to participate in the Plan as Designated
423 Corporations, (B) which Related Corporations or Affiliates will be eligible to participate in the Plan as Designated Non-423
Corporations, (C) which Designated Companies will participate in each separate Offering (to the extent that the Company makes separate
Offerings).

 

(iii)             
To construe and interpret the Plan and Purchase Rights, and to establish, amend and revoke rules and regulations for
its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan, in
a manner and to the extent it deems necessary or expedient to make the Plan fully effective.

 

     

     

    

 

(iv)               
 To settle all controversies regarding the Plan and Purchase Rights granted under the Plan.

 

(v)                
To suspend or terminate the Plan at any time as provided in Section 12.

 

(vi)               
To amend the Plan at any time as provided in Section 12.

 

(vii)             
Generally, to exercise such powers and to perform such acts as it deems necessary or expedient to promote the best interests
of the Company and its Related Corporations and to carry out the intent that the Plan be treated as an Employee Stock Purchase
Plan with respect to the 423 Component.

 

(viii)            
To adopt such rules, procedures and sub-plans as are necessary or appropriate to permit or facilitate participation
in the Plan by Employees who are foreign nationals or employed or located outside the United States. Without limiting the generality
of, and consistent with, the foregoing, the Board specifically is authorized to adopt rules, procedures, and sub-plans regarding,
without limitation, eligibility to participate in the Plan, the definition of eligible “earnings,” handling and making
of Contributions, establishment of bank or trust accounts to hold Contributions, payment of interest, conversion of local currency,
obligations to pay payroll tax, determination of beneficiary designation requirements, withholding procedures and handling of share
issuances, any of which may vary according to applicable requirements, and which, if applicable to a Designated Non-423 Corporation,
do not have to comply with the requirements of Section 423 of the Code.

 

(c)          
The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration
is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore
possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee any of the
administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the
Committee or subcommittee), subject, however, to such resolutions, not inconsistent with the provisions of the Plan, as may be
adopted from time to time by the Board. Further, to the extent not prohibited by Applicable Law, the Board or Committee may, from
time to time, delegate some or all of its authority under the Plan to one or more officers of the Company or other persons or groups
of persons as it deems necessary, appropriate or advisable under conditions or limitations that it may set at or after the time
of the delegation. The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time,
revest in the Board some or all of the powers previously delegated. Whether or not the Board has delegated administration of the
Plan to a Committee, the Board will have the final power to determine all questions of policy and expediency that may arise in
the administration of the Plan.

 

(d)           
All determinations, interpretations and constructions made by the Board in good faith will not be subject to review
by any person and will be final, binding and conclusive on all persons.

 

3.            
Shares of Common Stock Subject to the Plan.

 

(a)           Subject
to the provisions of Section 11(a) relating to Capitalization Adjustments, the maximum number of shares of Common Stock that
may be issued under the Plan will not exceed [_________] shares of Common Stock, plus the number of shares of Common Stock
that are automatically added on January 1st of each year for a period of up to ten years, commencing on the first
January 1 following the year in which the IPO Date occurs and ending on (and including) January 1, 2030, in an amount equal
to the lesser of (i) [_]% of the total number of shares of Common Stock outstanding on December 31st of the
preceding calendar year, and (ii) [________] shares of Common Stock. Notwithstanding the
foregoing, the Board may act prior to the first day of any calendar year to provide that there will be no January 1st increase
in the share reserve for such calendar year or that the increase in the share reserve for such calendar year will be a lesser
number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence. For the avoidance of doubt,
up to the maximum number of shares of Common Stock reserved under this Section 3(a) may be used to satisfy purchases of
Common Stock under the 423 Component and any remaining portion of such maximum number of shares may be used to satisfy
purchases of Common Stock under the Non-423 Component.

 

    2

     

    

 

(b)           
If any Purchase Right granted under the Plan terminates without having been exercised in full, the shares of Common
Stock not purchased under such Purchase Right will again become available for issuance under the Plan.

 

(c)          
The stock purchasable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including
shares repurchased by the Company on the open market.

 

4.            
Grant of Purchase Rights; Offering.

 

(a)          
The Board may from time to time grant or provide for the grant of Purchase Rights to Eligible Employees under an Offering
(consisting of one or more Purchase Periods) on an Offering Date or Offering Dates selected by the Board. Each Offering will be
in such form and will contain such terms and conditions as the Board will deem appropriate, and, with respect to the 423 Component,
will comply with the requirement of Section 423(b)(5) of the Code that all Employees granted Purchase Rights will have the same
rights and privileges. The terms and conditions of an Offering shall be incorporated by reference into the Plan and treated as
part of the Plan. The provisions of separate Offerings need not be identical, but each Offering will include (through incorporation
of the provisions of this Plan by reference in the document comprising the Offering or otherwise) the period during which the Offering
will be effective, which period will not exceed 27 months beginning with the Offering Date, and the substance of the provisions
contained in Sections 5 through 8, inclusive.

 

(b)          
If a Participant has more than one Purchase Right outstanding under the Plan, unless he or she otherwise indicates in
forms delivered to the Company or a third party designated by the Company (each, a “Company Designee”):
(i) each form will apply to all of his or her Purchase Rights under the Plan, and (ii) a Purchase Right with a lower exercise price
(or an earlier-granted Purchase Right, if different Purchase Rights have identical exercise prices) will be exercised to the fullest
possible extent before a Purchase Right with a higher exercise price (or a later-granted Purchase Right if different Purchase Rights
have identical exercise prices) will be exercised.

 

(c)          
The Board will have the discretion to structure an Offering so that if the Fair Market Value of a share of Common Stock
on the first Trading Day of a new Purchase Period within that Offering is less than or equal to the Fair Market Value of a share
of Common Stock on the Offering Date for that Offering, then (i) that Offering will terminate immediately as of that first Trading
Day, and (ii) the Participants in such terminated Offering will be automatically enrolled in a new Offering beginning on the first
Trading Day of such new Purchase Period.

 

5.            
Eligibility.

 

(a)           Purchase
Rights may be granted only to Employees of the Company or, as the Board may designate in accordance with Section 2(b), to
Employees of a Related Corporation or an Affiliate. Except as provided in Section 5(b) or as required by Applicable Law, an
Employee will not be eligible to be granted Purchase Rights unless, on the Offering Date, the Employee has been in the employ
of the Company or the Related Corporation or an Affiliate, as the case may be, for such continuous period preceding such
Offering Date as the Board may require, but in no event will the required period of continuous employment be equal to or
greater than two years. In addition, the Board may (unless prohibited by Applicable Law) provide that no Employee will be
eligible to be granted Purchase Rights under the Plan unless, on the Offering Date, such Employee’s customary
employment with the Company, the Related Corporation, or the Affiliate is more than 20 hours per week and more than five
months per calendar year or such other criteria as the Board may determine consistent with Section 423 of the Code with
respect to the 423 Component. The Board may also exclude from participation in the Plan or any Offering Employees who are
 "highly compensated employees" (within the meaning of Section 423(b)(4)(D) of the Code) of the Company or a Related
Corporation or a subset of such highly compensated employees.

 

    3

     

    

 

(b)          
The Board may provide that each person who, during the course of an Offering, first becomes an Eligible Employee will,
on a date or dates specified in the Offering which coincides with the day on which such person becomes an Eligible Employee or
which occurs thereafter, receive a Purchase Right under that Offering, which Purchase Right will thereafter be deemed to be a part
of that Offering. Such Purchase Right will have the same characteristics as any Purchase Rights originally granted under that Offering,
as described herein, except that:

 

(i)                
the date on which such Purchase Right is granted will be the “Offering Date” of such Purchase Right for
all purposes, including determination of the exercise price of such Purchase Right;

 

(ii)               
the period of the Offering with respect to such Purchase Right will begin on its Offering Date and end coincident with
the end of such Offering; and

 

(iii)             
the Board may provide that if such person first becomes an Eligible Employee within a specified period of time before
the end of the Offering, he or she will not receive any Purchase Right under that Offering.

 

(c)          
No Employee will be eligible for the grant of any Purchase Rights if, immediately after any such Purchase Rights are
granted, such Employee owns stock possessing five percent or more of the total combined voting power or value of all classes of
stock of the Company or of any Related Corporation. For purposes of this Section 5(c), the rules of Section 424(d) of the Code
will apply in determining the stock ownership of any Employee, and stock which such Employee may purchase under all outstanding
Purchase Rights and options will be treated as stock owned by such Employee.

 

(d)          
As specified by Section 423(b)(8) of the Code, an Eligible Employee may be granted Purchase Rights only if such Purchase
Rights, together with any other rights granted under all Employee Stock Purchase Plans of the Company and any Related Corporations,
do not permit such Eligible Employee’s rights to purchase stock of the Company or any Related Corporation to accrue at a
rate which, when aggregated, exceeds US $25,000 of Fair Market Value of such stock (determined at the time such rights are granted,
and which, with respect to the Plan, will be determined as of their respective Offering Dates) for each calendar year in which
such rights are outstanding at any time.

 

(e)          
Officers of the Company and any Designated Company, if they are otherwise Eligible Employees, will be eligible to participate
in Offerings under the Plan. Notwithstanding the foregoing, the Board may (unless prohibited by Applicable Law) provide in an Offering
that Employees who are highly compensated Employees within the meaning of Section 423(b)(4)(D) of the Code will not be eligible
to participate.

 

    4

     

    

 

(f)          
 Notwithstanding anything in this Section 5 to the contrary, in the case of an Offering under the Non-423 Component,
an Eligible Employee (or group of Eligible Employees) may be excluded from participation in the Plan or an Offering if the Board
has determined, in its sole discretion, that participation of such Eligible Employee(s) is not advisable or practical for any reason.

 

6.            
Purchase Rights; Purchase Price.

 

(a)          
On each Offering Date, each Eligible Employee, pursuant to an Offering made under the Plan, will be granted a Purchase
Right to purchase up to that number of shares of Common Stock purchasable either with a percentage or with a maximum dollar amount,
as designated by the Board, but in either case not exceeding 15% of such Employee’s earnings (as defined by the Board in
each Offering) during the period that begins on the Offering Date (or such later date as the Board determines for a particular
Offering) and ends on the date stated in the Offering, which date will be no later than the end of the Offering.

 

(b)          
The Board will establish one or more Purchase Dates during an Offering on which Purchase Rights granted for that Offering
will be exercised and shares of Common Stock will be purchased in accordance with such Offering.

 

(c)          
In connection with each Offering made under the Plan, the Board may specify (i) a maximum number of shares of Common
Stock that may be purchased by any Participant on any Purchase Date during such Offering, (ii) a maximum aggregate number of shares
of Common Stock that may be purchased by all Participants pursuant to such Offering and/or (iii) a maximum aggregate number of
shares of Common Stock that may be purchased by all Participants on any Purchase Date under the Offering. If the aggregate purchase
of shares of Common Stock issuable upon exercise of Purchase Rights granted under the Offering would exceed any such maximum aggregate
number, then, in the absence of any Board action otherwise, a pro rata (based on each Participant’s accumulated Contributions)
allocation of the shares of Common Stock (rounded down to the nearest whole share) available will be made in as nearly a uniform
manner as will be practicable and equitable.

 

(d)          
The purchase price of shares of Common Stock acquired pursuant to Purchase Rights will be not less than the lesser of:

 

(i)                
an amount equal to 85% of the Fair Market Value of the shares of Common Stock on the Offering Date; or

 

(ii)               
an amount equal to 85% of the Fair Market Value of the shares of Common Stock on the applicable Purchase Date.

 

7.            
Participation; Withdrawal; Termination.

 

(a)          An
Eligible Employee may elect to participate in an Offering and authorize payroll deductions as the means of making
Contributions by completing and delivering to the Company or a Company Designee, within the time specified in the Offering,
an enrollment form provided by the Company or Company Designee. The enrollment form will specify the amount of Contributions
not to exceed the maximum amount specified by the Board. Each Participant’s Contributions will be credited to a
bookkeeping account for such Participant under the Plan and will be deposited with the general funds of the Company except
where Applicable Law requires that Contributions be deposited with a third party. If permitted in the Offering, a Participant
may begin such Contributions with the first payroll occurring on or after the Offering Date (or, in the case of a payroll
date that occurs after the end of the prior Offering but before the Offering Date of the next new Offering, Contributions
from such payroll will be included in the new Offering). If permitted in the Offering, a Participant may thereafter reduce
(including to zero) or increase his or her Contributions. If required under Applicable Law or if specifically provided in the
Offering, in addition to or instead of making Contributions by payroll deductions, a Participant may make Contributions
through payment by cash, check or wire transfer prior to a Purchase Date.

 

    5

     

    

 

(b)          
During an Offering, a Participant may cease making Contributions and withdraw from the Offering by delivering to the
Company or a Company Designee a withdrawal form provided by the Company. The Company may impose a deadline before a Purchase Date
for withdrawing. Upon such withdrawal, such Participant’s Purchase Right in that Offering will immediately terminate and
the Company will distribute as soon as practicable to such Participant all of his or her accumulated but unused Contributions and
such Participant’s Purchase Right in that Offering shall thereupon terminate. A Participant’s withdrawal from that
Offering will have no effect upon his or her eligibility to participate in any other Offerings under the Plan, but such Participant
will be required to deliver a new enrollment form to participate in subsequent Offerings.

 

(c)          
Unless otherwise required by Applicable Law, Purchase Rights granted pursuant to any Offering under the Plan will terminate
immediately if the Participant either (i) is no longer an Employee for any reason or for no reason (subject to any post-employment
participation period required by Applicable Law) or (ii) is otherwise no longer eligible to participate. The Company will distribute
as soon as practicable to such individual all of his or her accumulated but unused Contributions.

 

(d)          
Unless otherwise determined by the Board, a Participant whose employment transfers or whose employment terminates with
an immediate rehire (with no break in service) by or between the Company and a Designated Company or between Designated Companies
will not be treated as having terminated employment for purposes of participating in the Plan or an Offering; however, if a Participant
transfers from an Offering under the 423 Component to an Offering under the Non-423 Component, the exercise of the Participant’s
Purchase Right will be qualified under the 423 Component only to the extent such exercise complies with Section 423 of the Code.
If a Participant transfers from an Offering under the Non-423 Component to an Offering under the 423 Component, the exercise of
the Purchase Right will remain non-qualified under the Non-423 Component. The Board may establish different and additional rules
governing transfers between separate Offerings within the 423 Component and between Offerings under the 423 Component and Offerings
under the Non-423 Component.

 

(e)         
During a Participant’s lifetime, Purchase Rights will be exercisable only by such Participant. Purchase Rights
are not transferable by a Participant, except by will, by the laws of descent and distribution, or, if permitted by the Company,
by a beneficiary designation as described in Section 10.

 

(f)          
Unless otherwise specified in the Offering or as required by Applicable Law, the Company will have no obligation to
pay interest on Contributions.

 

8.            
Exercise of Purchase Rights.

 

(a)          
On each Purchase Date, each Participant’s accumulated Contributions will be applied to the purchase of shares
of Common Stock, up to the maximum number of shares of Common Stock permitted by the Plan and the applicable Offering, at the purchase
price specified in the Offering. No fractional shares will be issued unless specifically provided for in the Offering.

 

(b)           Unless
otherwise provided in the Offering, if any amount of accumulated Contributions remains in a Participant’s account after
the purchase of shares of Common Stock on the final Purchase Date of an Offering, then such remaining amount will not roll
over to the next Offering and will instead be distributed in full to such Participant after the final Purchase Date of such
Offering without interest (unless otherwise required by Applicable Law).

 

    6

     

    

 

(c)          
No Purchase Rights may be exercised to any extent unless the shares of Common Stock to be issued upon such exercise
under the Plan are covered by an effective registration statement pursuant to the Securities Act and the Plan is in material compliance
with all applicable U.S. federal and state, foreign and other securities, exchange control and other laws applicable to the Plan.
If on a Purchase Date the shares of Common Stock are not so registered or the Plan is not in such compliance, no Purchase Rights
will be exercised on such Purchase Date, and the Purchase Date will be delayed until the shares of Common Stock are subject to
such an effective registration statement and the Plan is in material compliance, except that the Purchase Date will in no event
be more than 27 months from the Offering Date. If, on the Purchase Date, as delayed to the maximum extent permissible, the shares
of Common Stock are not registered and the Plan is not in material compliance with all Applicable Laws, as determined by the Company
in its sole discretion, no Purchase Rights will be exercised and all accumulated but unused Contributions will be distributed to
the Participants without interest (unless the payment of interest is otherwise required by Applicable Law).

 

9.           
Covenants of the Company.

 

The Company will seek
to obtain from each U.S. federal or state, foreign or other regulatory commission, agency or other Governmental Body having jurisdiction
over the Plan such authority as may be required to grant Purchase Rights and issue and sell shares of Common Stock thereunder unless
the Company determines, in its sole discretion, that doing so is not practical or would cause the Company to incur costs that are
unreasonable. If, after commercially reasonable efforts, the Company is unable to obtain the authority that counsel for the Company
deems necessary for the grant of Purchase Rights or the lawful issuance and sale of Common Stock under the Plan, and at a commercially
reasonable cost, the Company will be relieved from any liability for failure to grant Purchase Rights and/or to issue and sell
Common Stock upon exercise of such Purchase Rights.

 

10.          
Designation of Beneficiary.

 

(a)          
The Company may, but is not obligated to, permit a Participant to submit a form designating a beneficiary who will receive
any shares of Common Stock and/or Contributions from the Participant’s account under the Plan if the Participant dies before
such shares and/or Contributions are delivered to the Participant. The Company may, but is not obligated to, permit the Participant
to change such designation of beneficiary. Any such designation and/or change must be on a form approved by the Company.

 

(b)        
 If a Participant dies, and in the absence of a valid beneficiary designation, the Company will deliver any shares of
Common Stock and/or Contributions to the executor or administrator of the estate of the Participant. If no executor or administrator
has been appointed (to the knowledge of the Company), the Company, in its sole discretion, may deliver such shares of Common Stock
and/or Contributions, without interest (unless the payment of interest is otherwise required by Applicable Law), to the Participant’s
spouse, dependents or relatives, or if no spouse, dependent or relative is known to the Company, then to such other person as the
Company may designate.

 

11.          
Adjustments upon Changes in Common Stock; Corporate Transactions.

 

(a)           In
the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust: (i) the class(es) and
maximum number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number of
securities by which the share reserve is to increase automatically each year pursuant to Section 3(a),
(iii) the class(es) and number of securities subject to, and the purchase price applicable to outstanding Offerings and
Purchase Rights, and (iv) the class(es) and number of securities that are the subject of the purchase limits under each
ongoing Offering. The Board will make these adjustments, and its determination will be final, binding and
conclusive.

 

    7

     

    

 

(b)         
In the event of a Corporate Transaction, then: (i) any surviving corporation or acquiring corporation (or the surviving
or acquiring corporation’s parent company) may assume or continue outstanding Purchase Rights or may substitute similar rights
(including a right to acquire the same consideration paid to the stockholders in the Corporate Transaction) for outstanding Purchase
Rights, or (ii) if any surviving or acquiring corporation (or its parent company) does not assume or continue such Purchase Rights
or does not substitute similar rights for such Purchase Rights, then the Participants’ accumulated Contributions will be
used to purchase shares of Common Stock (rounded down to the nearest whole share) within ten business days (or such other period
specified by the Board) prior to the Corporate Transaction under the outstanding Purchase Rights, and the Purchase Rights will
terminate immediately after such purchase.

 

12.          
Amendment, Termination or Suspension of the Plan.

 

(a)          
The Board may amend the Plan at any time in any respect the Board deems necessary or advisable. However, except as provided
in Section 11(a) relating to Capitalization Adjustments, stockholder approval will be required for any amendment of the Plan for
which stockholder approval is required by Applicable Law.

 

(b)          
The Board may suspend or terminate the Plan at any time. No Purchase Rights may be granted under the Plan while the
Plan is suspended or after it is terminated.

 

Any benefits, privileges,
entitlements and obligations under any outstanding Purchase Rights granted before an amendment, suspension or termination of the
Plan will not be materially impaired by any such amendment, suspension or termination except (i) with the consent of the person
to whom such Purchase Rights were granted, (ii) as necessary to facilitate compliance with any laws, listing requirements, or governmental
regulations (including, without limitation, the provisions of Section 423 of the Code and the regulations and other interpretive
guidance issued thereunder relating to Employee Stock Purchase Plans) including without limitation any such regulations or other
guidance that may be issued or amended after the date the Plan is adopted by the Board, or (iii) as necessary to obtain or maintain
favorable tax, listing, or regulatory treatment. To be clear, the Board may amend outstanding Purchase Rights without a Participant’s
consent if such amendment is necessary to ensure that the Purchase Right and/or the Plan complies with the requirements of Section
423 of the Code with respect to the 423 Component or with respect to other Applicable Laws. Notwithstanding anything in the Plan
or any Offering Document to the contrary, the Board will be entitled to: (i) establish the exchange ratio applicable to amounts
withheld in a currency other than U.S. dollars; (ii) permit Contributions in excess of the amount designated by a Participant in
order to adjust for mistakes in the Company’s processing of properly completed Contribution elections; (iii) establish reasonable
waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of
Common Stock for each Participant properly correspond with amounts withheld from the Participant’s Contributions; (iv) amend
any outstanding Purchase Rights or clarify any ambiguities regarding the terms of any Offering to enable the Purchase Rights to
qualify under and/or comply with Section 423 of the Code with respect to the 423 Component; and (v) establish other limitations
or procedures as the Board determines in its sole discretion advisable that are consistent with the Plan. The actions of the Board
pursuant to this paragraph will not be considered to alter or impair any Purchase Rights granted under an Offering as they are
part of the initial terms of each Offering and the Purchase Rights granted under each Offering.

 

    8

     

    

 

13.          
 Tax Qualification; Tax Withholding.

 

(a)         
Although the Company may endeavor to (i) qualify a Purchase Right for special tax treatment under the laws of the United
States or jurisdictions outside of the United States or (ii) avoid adverse tax treatment, the Company makes no representation to
that effect and expressly disavows any covenant to maintain special or to avoid unfavorable tax treatment, notwithstanding anything
to the contrary in this Plan.  The Company will be unconstrained in its corporate activities without regard to the potential
negative tax impact on Participants.

 

(b)          
Each Participant will make arrangements, satisfactory to the Company and any applicable Related Corporation, to enable
the Company or the Related Corporation to fulfill any withholding obligation for Tax-Related Items. Without limitation to the foregoing,
in the Company’s sole discretion and subject to Applicable Law, such withholding obligation may be satisfied in whole or
in part by (i) withholding from the Participant’s salary or any other cash payment due to the Participant from the Company
or a Related Corporation; (ii) withholding from the proceeds of the sale of shares of Common Stock acquired under the Plan, either
through a voluntary sale or a mandatory sale arranged by the Company; or (iii) any other method deemed acceptable by the Board.
The Company shall not be required to issue any shares of Common Stock under the Plan until such obligations are satisfied.

 

14.          
Effective Date of Plan.

 

The Plan will become
effective immediately prior to and contingent upon the IPO Date. No Purchase Rights will be exercised unless and until the Plan
has been approved by the stockholders of the Company, which approval must be within 12 months before or after the date the Plan
is adopted (or if required under Section 12(a) above, materially amended) by the Board.

 

15.          
Miscellaneous Provisions.

 

(a)          
Proceeds from the sale of shares of Common Stock pursuant to Purchase Rights will constitute general funds of the Company.

 

(b)          
A Participant will not be deemed to be the holder of, or to have any of the rights of a holder with respect to, shares
of Common Stock subject to Purchase Rights unless and until the Participant’s shares of Common Stock acquired upon exercise
of Purchase Rights are recorded in the books of the Company (or its transfer agent).

 

(c)          
The Plan and Offering do not constitute an employment contract. Nothing in the Plan or in the Offering will in any way
alter the at will nature of a Participant’s employment or amend a Participant’s employment contract, if applicable,
or be deemed to create in any way whatsoever any obligation on the part of any Participant to continue in the employ of the Company
or a Related Corporation or an Affiliate, or on the part of the Company, a Related Corporation or an Affiliate to continue the
employment of a Participant.

 

(d)          
The provisions of the Plan will be governed by the laws of the State of Delaware without resort to that state’s
conflicts of laws rules.

 

(e)          
If any particular provision of the Plan is found to be invalid or otherwise unenforceable, such provision will not affect
the other provisions of the Plan, but the Plan will be construed in all respects as if such invalid provision were omitted.

 

    9

     

    

 

(f)         
 If any provision of the Plan does not comply with Applicable Law, such provision shall be construed in such a manner
as to comply with Applicable Law.

 

16.          
Definitions.

 

As used in the Plan,
the following definitions will apply to the capitalized terms indicated below:

 

(a)          
“423 Component” means the part of the Plan, which excludes the Non-423 Component, pursuant
to which Purchase Rights that satisfy the requirements for an Employee Stock Purchase Plan may be granted to Eligible Employees.

 

(b)         
“Affiliate” means any entity, other than a Related Corporation, whether now or subsequently established,
which is at the time of determination, a “parent” or “subsidiary” of the Company as such terms are defined
in Rule 405 promulgated under the Securities Act. The Board may determine the time or times at which “parent” or “subsidiary”
status is determined within the foregoing definition.

 

(c)          
“Applicable Law” means shall mean the Code and any applicable securities, federal, state,
foreign, material local or municipal or other law, statute, constitution, principle of common law, resolution, ordinance, code,
edict, decree, rule, listing rule, regulation, judicial decision, ruling or requirement issued, enacted, adopted, promulgated,
implemented or otherwise put into effect by or under the authority of any Governmental Body (or under the authority of the NASDAQ
Stock Market or the Financial Industry Regulatory Authority).

 

(d)          
“Board” means the board of directors of the Company.

 

(e)          
“Capitalization Adjustment” means any change that is made in, or other events that occur with
respect to, the Common Stock subject to the Plan or subject to any Purchase Right after the date the Plan is adopted by the Board
without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation,
stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, liquidating dividend, combination
of shares, exchange of shares, change in corporate structure or other similar equity restructuring transaction, as that term is
used in Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding
the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.

 

(f)          
 “Code” means the U.S. Internal Revenue Code of 1986, as amended, including any applicable
regulations and guidance thereunder.

 

(g)          
“Committee” means a committee of one or more members of the Board to whom authority has been
delegated by the Board in accordance with Section 2(c).

 

(h)          
“Common Stock” means the common stock of the Company.

 

(i)          
 “Company” means Olema Pharmaceuticals, Inc., a Delaware corporation.

 

(j)          
“Contributions” means the payroll deductions and other additional payments specifically provided
for in the Offering that a Participant contributes to fund the exercise of a Purchase Right. A Participant may make additional
payments into his or her account if specifically provided for in the Offering, and then only if the Participant has not already
had the maximum permitted amount withheld during the Offering through payroll deductions.

 

    10

     

    

 

(k)        
 “Corporate Transaction” means the consummation, in a single transaction or in a series of
related transactions, of any one or more of the following events:

 

(i)                 
a sale or other disposition of all or substantially all, as determined by the Board in its sole discretion, of the consolidated
assets of the Company and its subsidiaries;

 

(ii)               
a sale or other disposition of more than 50% of the outstanding securities of the Company;

 

(iii)              
a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or

 

(iv)              
a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares
of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by
virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.

 

(l)           
“Designated 423 Corporation” means any Related Corporation selected by the Board to participate in
the 423 Component.

 

(m)         
“Designated Company” means any Designated Non-423 Corporation or Designated 423 Corporation, provided,
however, that at any given time, a Related Corporation participating in the 423 Component shall not be a Related Corporation participating
in the Non-423 Component.

 

(n)         
“Designated Non-423 Corporation” means any Related Corporation or Affiliate selected by the Board
to participate in the Non-423 Component.

 

(o)          
“Director” means a member of the Board.

 

(p)          
“Eligible Employee” means an Employee who meets the requirements set forth in the document(s)
governing the Offering for eligibility to participate in the Offering, provided that such Employee also meets the requirements
for eligibility to participate set forth in the Plan.

 

(q)          
“Employee” means any person, including an Officer or Director, who is “employed”
for purposes of Section 423(b)(4) of the Code by the Company or a Related Corporation, or solely with respect to the Non-423 Component,
an Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered
an “Employee” for purposes of the Plan.

 

(r)          
“Employee Stock Purchase Plan” means a plan that grants Purchase Rights intended to be options
issued under an “employee stock purchase plan,” as that term is defined in Section 423(b) of the Code.

 

(s)          
“Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended and the rules and
regulations promulgated thereunder.

 

(t)           
“Fair Market Value” means, as of any date, the value of the Common Stock determined as follows:

 

(i)                 If
the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a
share of Common Stock will be the closing sales price for such stock as quoted on such exchange or market (or the exchange or
market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in such source as
the Board deems reliable. Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on
the date of determination, then the Fair Market Value will be the closing sales price on the last preceding date for which
such quotation exists.

 

    11

     

    

 

(ii)               
In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith
in compliance with Applicable Laws and regulations and, to the extent applicable as determined in the sole discretion of the Board,
in a manner that complies with Sections 409A of the Code

 

(iii)              
Notwithstanding the foregoing, for any Offering that commences on the IPO Date, the Fair Market Value of the shares
of Common Stock on the Offering Date will be the price per share at which shares are first sold to the public in the Company’s
initial public offering as specified in the final prospectus for that initial public offering.

 

(u)          
“Governmental Body” means any: (a) nation, state, commonwealth, province, territory, county,
municipality, district or other jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government;
(c) governmental or regulatory body, or quasi-governmental body of any nature (including any governmental division, department,
administrative agency or bureau, commission, authority, instrumentality, official, ministry, fund, foundation, center, organization,
unit, body or entity and any court or other tribunal, and for the avoidance of doubt, any tax authority) or other body exercising
similar powers or authority; or (d) self-regulatory organization (including the NASDAQ Stock Market and the Financial Industry
Regulatory Authority).

 

(v)           
“IPO Date” means the date of the underwriting agreement between the Company and the underwriters
managing the initial public offering of the Common Stock, pursuant to which the Common Stock is priced for the initial public offering.

 

(w)         
“Non-423 Component” means the part of the Plan, which excludes the 423 Component, pursuant
to which Purchase Rights that are not intended to satisfy the requirements for an Employee Stock Purchase Plan may be granted to
Eligible Employees.

 

(x)          
“Offering” means the grant to Eligible Employees of Purchase Rights, with the exercise of
those Purchase Rights automatically occurring at the end of one or more Purchase Periods. The terms and conditions of an Offering
will generally be set forth in the “Offering Document” approved by the Board for that Offering.

 

(y)           
“Offering Date” means a date selected by the Board for an Offering to commence.

 

(z)           
“Officer” means a person who is an officer of the Company or a Related Corporation within
the meaning of Section 16 of the Exchange Act.

 

(aa)       
 “Participant” means an Eligible Employee who holds an outstanding Purchase Right.

 

(bb)        
“Plan” means this Olema Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan, as amended
from time to time, including both the 423 Component and the Non-423 Component.

 

(cc)         
“Purchase Date” means one or more dates during an Offering selected by the Board on which
Purchase Rights will be exercised and on which purchases of shares of Common Stock will be carried out in accordance with such
Offering.

 

    12

     

    

 

(dd)       
 “Purchase Period” means a period of time specified within an Offering, generally beginning
on the Offering Date or on the first Trading Day following a Purchase Date, and ending on a Purchase Date. An Offering may consist
of one or more Purchase Periods.

 

(ee)        
“Purchase Right” means an option to purchase shares of Common Stock granted pursuant to the
Plan.

 

(ff)        
“Related Corporation” means any “parent corporation” or “subsidiary corporation”
of the Company whether now or subsequently established, as those terms are defined in Sections 424(e) and (f), respectively, of
the Code.

 

(gg)        
“Securities Act” means the U.S. Securities Act of 1933, as amended.

 

(hh)       
“Tax-Related Items” means any income tax, social insurance, payroll tax, fringe benefit tax,
payment on account or other tax-related items arising out of or in relation to a Participant’s participation in the Plan,
including, but not limited to, the exercise of a Purchase Right and the receipt of shares of Common Stock or the sale or other
disposition of shares of Common Stock acquired under the Plan.

 

(ii)          
“Trading Day” means any day on which the exchange(s) or market(s) on which shares of Common
Stock are listed, including but not limited to the NYSE, Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital
Market or any successors thereto, is open for trading.

 

    13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00316-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00316-of-00352.parquet"}]]